GP preferences for discussing statin deprescribing: a discrete choice experiment
Date: 2021
Thompson, Wade, et al. “GP preferences for discussing statin deprescribing: a discrete choice experiment.” Family Practice (2021).
Leveraging implementation science to increase the translation of deprescribing evidence into practice
Date: 2021
Citation: Ailabouni, Nagham J., et al. “Leveraging implementation science to increase the translation of deprescribing evidence into practice.” Research in Social and Administrative Pharmacy (2021).
Appropriate deprescribing in older people: a challenging necessity Commentary to accompany themed collection on deprescribing
Date: 2021
Citation: van der Velde, Nathalie, and Jatinder S. Minhas. “Appropriate deprescribing in older people: a challenging necessity Commentary to accompany themed collection on deprescribing.” Age and Ageing (2021).
Unexpected Findings During Double-blind Discontinuation of Acetylcholinesterase Inhibitor Medications
Date: 2021
Citation: Moo, Lauren R., et al. “Unexpected Findings During Double-blind Discontinuation of Acetylcholinesterase Inhibitor Medications.” Clinical Therapeutics (2021).
Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected data
Date: 2021
Citation: Moriarty, Frank, Wade Thompson, and Fiona Boland. “Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected data.” Research in Social and Administrative Pharmacy (2021).
Deprescribing in older patients by early-career general practitioners: Prevalence and associations
Date: 2021
Citation: Magin, Parker, et al. “Deprescribing in older patients by early‐career general practitioners: prevalence and associations.” International journal of clinical practice (2021): e14325.